Key result
Generation of a knock-in mouse model carrying the RyR2-Q3924E mutation resulted in significant cardiac hypertrophy and lethality before 3 weeks of age, preventing germline transmission.
Why the study?
To determine the in situ cardiac phenotype in an animal model of a lethal RyR2 Ca2+ binding site point mutation previously characterized in hiPSC-CMs.
What is the in situ cardiac phenotype of the RyR2-Q3924E mutation in a transgenic mouse model?
What is the in situ cardiac phenotype of the RyR2-Q3924E mutation in a transgenic mouse model?
The RyR2-Q3924E mutation is lethal in a transgenic mouse model, causing significant cardiac hypertrophy and death before 3 weeks of age.
RyR2-Q3924E is lethal with hypertrophy in mice; leaves open its pathogenicity in human RyR2 cardiomyopathy.
Over 200 point mutations in the ryanodine receptor (RyR2) of the cardiac sarcoplasmic reticulum (SR) are known to be associated with cardiac arrhythmia. We have already reported on the calcium signaling phenotype of a point mutation in RyR2 Ca2+ binding site Q3925E expressed in human stem-cell-derived cardiomyocytes (hiPSC-CMs) that was found to be lethal in a 9-year-old girl. CRISPR/Cas9-gene-edited mutant cardiomyocytes carrying the RyR2-Q3925E mutation exhibited a loss of calcium-induced calcium release (CICR) and caffeine-triggered calcium release but continued to beat arrhythmically without generating significant SR Ca2+ release, consistent with a remodeling of the calcium signaling pathway. An RNAseq heat map confirmed significant changes in calcium-associated genes, supporting the possibility of remodeling. To determine the in situ cardiac phenotype in an animal model of this mutation, we generated a knock-in mouse model of RyR2-Q3924E+/− using the CRISPR/Cas9 technique. We obtained three homozygous and one chimera mice, but they all died before reaching 3 weeks of age, preventing the establishment of germline mutation transmission in their offspring. A histo-pathological analysis of the heart showed significant cardiac hypertrophy, suggesting the Q3924E-RyR2 mutation was lethal to the mice.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2024) studied Cardiac arrhythmia / RyR2 mutation (n=4). RyR2-Q3924E mutation via CRISPR/Cas9 was evaluated on Survival and establishment of germline mutation transmission. Generation of a knock-in mouse model carrying the RyR2-Q3924E mutation resulted in significant cardiac hypertrophy and lethality before 3 weeks of age, preventing germline transmission.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: